Children (n=11) and adults (n=34, all aged under 70) with a form of blood cancer.
Almost half of adult patients had clinically-significant genomic results, suggesting the test may be useful.
Few genomic variants were found in child patients, suggesting the test is unlikely to provide more information than existing tests.